http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009128878-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8564b39cec4bf49f3396ebcb134cbb93 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb77dad9281a6322c07147062b24c899 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3e92254e002e7fda99e662e0ffe567f |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-10021 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-525 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 |
| filingDate | 2009-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb4ba875113375446f85fa96be463a5f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3ee84f6d78a33351707b240377b61fa |
| publicationDate | 2009-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2009128878-A1 |
| titleOfInvention | CHIMERIC PORCINE CIRCOVIRUS PCV2Gen-1Rep AND USES THEREOF |
| abstract | The present invention relates to a novel chimeric nucleic acid molecule of porcine circovirus (PCV2Gen-lRep) that embraces a nucleic acid molecule encoding porcine circovirus type 2 (PCV2) which contains a nucleic acid sequence encoding a Rep protein of porcine circovirus type 1 (PCVl), particularly wherein the nucleic acid sequence encoding the Rep protein of PCVl is an open reading frame (ORF) gene and, more particularly, wherein the ORF Rep gene is ORFl. A highly desirable chimeric nucleic acid molecule is constructed by replacing the ORFl Rep gene of PCV2 by the ORFl Rep gene of PCVl. The invention also encompasses the biologically functional plasmid or viral vector containing the unique chimeric nucleic acid molecules, suitable host cells transfected by the plasmid or vector, infectious chimeric porcine circoviruses that are produced by the suitable host cells, the process for the production of an immunogenic polypeptide product making use of the new chimera, viral vaccines that protect a pig against viral infection or postweaning multisystemic wasting syndrome (PMWS) caused by PCV2, methods of protecting a pig against viral infection or postweaning multisystemic wasting syndrome (PMWS) caused by PCV2, methods of preparing the unique chimera of PCV2Gen-lRep and the like. This invention further includes a new method for improving the replication and titer of PCV2 in a cell culture. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109535229-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109535229-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013030608-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2750704-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9561270-B2 |
| priorityDate | 2008-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 126.